Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23239729 | 0.94 | KDM4E (0.33) | KDM4EATML3MBTL1HSD17B10TSHR | |
| SCHEMBL24398524 | 0.92 | AVPR1A (0.31) | HSD17B10TSHRMEN1GAAKMT2A | |
| SCHEMBL18639104 | 0.91 | L3MBTL1 (0.34) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL19658790 | 0.91 | KDM4E (0.33) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL18060058 | 0.90 | HSD17B10 (0.30) | KDM4EATML3MBTL1HSD17B10TSHR | |
| SCHEMBL20989408 | 0.90 | AVPR1A (0.35) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL19646318 | 0.88 | AVPR1A (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL22460115 | 0.86 | KDM4E (0.33) | KDM4EATML3MBTL1MEN1GAA | |
| SCHEMBL24802387 | 0.85 | — | — | |
| SCHEMBL21022951 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10340460-B2 | Organic electroluminescent element | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2019-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10340460-B2 | Organic electroluminescent element | EML4, LAGE3, ELOC | KDM4E 746/4885ATM 3518/4885L3MBTL1 278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.